Mental health services in England are being overwhelmed because of rapidly rising demand, workforce shortages, and lack of funding, according to a new report.
A new analysis by the British Medical Association says millions of people could be affected by NHS cuts under regional efficiency plans, which have cost millions of pounds to set up.
England’s NHS is to axe the 18-week maximum waiting target for operations in favour of other priorities such as cancer treatments - a clear admission that the system is struggling financial
The US FDA announced today that it has cleared two novel gene therapies for sickle cell disease: Vertex Pharmaceuticals' Casgevy and bluebird bio's Lyfgenia.
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio